CARDINAL HEALTH, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 97.43 USD | -0.62% |
|
-2.30% | -3.34% |
| May. 07 | Cardinal Health Board of Directors Approves Increase to Quarterly Dividend, Payable on July 15, 2024 | CI |
| May. 07 | Deutsche Bank Adjusts Price Target on Cardinal Health to $110 From $116 | MT |
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Hours!
Take advantage of the offer
* See conditions on site
Financials (USD)
| Sales 2024 * | 226B | Sales 2025 * | 213B | Capitalization | 23.88B |
|---|---|---|---|---|---|
| Net income 2024 * | 955M | Net income 2025 * | 1.45B | EV / Sales 2024 * | 0.11 x |
| Net Debt 2024 * | 732M | Net cash position 2025 * | 376M | EV / Sales 2025 * | 0.11 x |
| P/E ratio 2024 * |
24.9
x | P/E ratio 2025 * |
15.7
x | Employees | 47,520 |
| Yield 2024 * |
2.06% | Yield 2025 * |
2.09% | Free-Float | 74.15% |
More Fundamentals
* Assessed data
More news
Latest transcript on Cardinal Health, Inc.
More recommendations
More press releases
| 1 day | -0.62% | ||
| 1 week | -2.30% | ||
| Current month | -5.44% | ||
| 1 month | -8.97% | ||
| 3 months | -5.91% | ||
| 6 months | -5.32% | ||
| Current year | -3.34% |
1 week
96.95
100.09
1 month
96.95108.42
Current year
96.95116.04
1 year
80.90116.04
3 years
45.85116.04
5 years
39.05116.04
10 years
39.05116.04
| Managers | Title | Age | Since |
|---|---|---|---|
Jason Hollar
CEO | Chief Executive Officer | 51 | 20-04-26 |
Aaron Alt
DFI | Director of Finance/CFO | 53 | 23-02-09 |
Michelle Greene
CTO | Chief Tech/Sci/R&D Officer | 54 | 20-12-31 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 55 | 22-09-05 | |
| Director/Board Member | 71 | 13-09-11 | |
Gregory Kenny
CHM | Chairman | 71 | 06-12-31 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-14 | 97.43 | -0.62% | 1,331,219 |
| 24-05-13 | 98.04 | -1.50% | 1,392,199 |
| 24-05-10 | 99.53 | +1.50% | 1,726,388 |
| 24-05-09 | 98.06 | +0.64% | 1,822,515 |
| 24-05-08 | 97.44 | -2.29% | 2,280,705 |
Delayed Quote Nyse, May 14, 2024 at 04:00 pm EDT
More quotes
Cardinal Health, Inc. is specialized in the distribution of products and health services to pharmacies, hospitals and medical practices. Net sales break down by activity as follows:
- distribution of pharmaceutical products (92.7%);
- distribution of medical, surgical and laboratory products (7.3%). The group also develops a manufacturing of medical and surgical products activity (masks, overalls, gloves, diagnostic products, products of aspiration and collection of liquids, radiology intervention, respiratory assistance, etc.).
The United States accounts for 97.7% of net sales.
Sector
Pharmaceuticals
Calendar
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
C+
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
16
Last Close Price
98.04
USD
Average target price
112.4
USD
Spread / Average Target
+14.60%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -3.34% | 23.88B | |
| +19.14% | 72.09B | |
| +10.27% | 8.89B | |
| +12.67% | 8.46B | |
| -17.41% | 8.29B | |
| +9.65% | 4.9B | |
| +21.40% | 4.34B | |
| -1.41% | 3.98B | |
| -1.99% | 3.89B | |
| +27.43% | 3.86B |
- Stock Market
- Equities
- CAH Stock